16.06.2010

Welcome To Pharma 3.0

Metamorphosis - In our first article in the Welcome to Pharma 3.0 series, "A New Business Model for Delivering Sustained Value," (CHEManager Europe 2-3/2010), we described how the industry's legacy business 1.0 model, based on marketing blockbuster drugs, is currently morphing into a more diversified 2.0 model. more01.06.2010

Protecting the Crown Jewels

No Risk - Whether you are outsourcing product development or manufacture, it is crucial to ensure that you have a clear understanding of all intellectual property aspects of the transaction, and that you put in place a well-drafted contract that protects your intellectual property (IP) and ensures adequate rights in relation to any new IP generated. A failure to do so can have many consequences, but at its worst it will mean that you won't own new IP that you had expected to own, and your confidential information could have found its way into the public domain. more